chr11-22218255-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM3PP4PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_213599.3: c.148C>T p.(Arg50Ter) variant in ANO5 is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 4/22 leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in at least two individuals with LGMD, including confirmed in trans with a pathogenic or likely pathogenic variant (c.191dup, 1.0 pt, PMID:23041008) (PM3). At least one patient with this variant displayed progressive limb girdle muscle weakness (PMID:28403181; PP4). This variant is absent from gnomAD v3.1.2 and v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): PVS1, PM3, PP4, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA379924765/MONDO:0015152/188
Frequency
Consequence
NM_213599.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151904Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461268Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726944
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151904Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74174
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1
The NM_213599.3: c.148C>T p.(Arg50Ter) variant in ANO5 is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 4/22 leading to nonsense mediated decay in a gene in which loss of function is an established disease mechanism (PVS1). This variant has been detected in at least two individuals with LGMD, including confirmed in trans with a pathogenic or likely pathogenic variant (c.191dup, 1.0 pt, PMID: 23041008) (PM3). At least one patient with this variant displayed progressive limb girdle muscle weakness (PMID: 28403181; PP4). This variant is absent from gnomAD v3.1.2 and v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): PVS1, PM3, PP4, PM2_Supporting. -
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L;C2750076:Miyoshi muscular dystrophy 3 Pathogenic:1
- -
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg50*) in the ANO5 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in combination with another ANO5 variant in an individual affected with pseudo-metabolic myopathy (PMID: 23041008). ClinVar contains an entry for this variant (Variation ID: 468825). Loss-of-function variants in ANO5 are known to be pathogenic (PMID: 25891276, 23606453, 21186264). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at